These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9068925)

  • 1. Will routine therapeutic drug monitoring have a place in clozapine therapy?
    Freeman DJ; Oyewumi LK
    Clin Pharmacokinet; 1997 Feb; 32(2):93-100. PubMed ID: 9068925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring of clozapine treatment. Therapeutic threshold value for serum clozapine concentrations.
    Olesen OV
    Clin Pharmacokinet; 1998 Jun; 34(6):497-502. PubMed ID: 9646010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine plasma level monitoring: current status.
    Cooper TB
    Psychiatr Q; 1996; 67(4):297-311. PubMed ID: 8938830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 and therapeutic drug monitoring with respect to clozapine.
    Buur-Rasmussen B; Brøsen K
    Eur Neuropsychopharmacol; 1999 Dec; 9(6):453-9. PubMed ID: 10625111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response.
    Mauri MC; Volonteri LS; Colasanti A; Fiorentini A; De Gaspari IF; Bareggi SR
    Clin Pharmacokinet; 2007; 46(5):359-88. PubMed ID: 17465637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
    Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is an adequate trial with clozapine?: therapeutic drug monitoring and time to response in treatment-refractory schizophrenia.
    Schulte P
    Clin Pharmacokinet; 2003; 42(7):607-18. PubMed ID: 12844323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].
    Papetti F; Morel-Pingault V; Buisse V; Maziere L; Banayan M; Thauby S; Besnard T; Darcourt G; Pringuey D
    Encephale; 2007 Oct; 33(5):811-8. PubMed ID: 18357853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum clozapine levels: a review of their clinical utility.
    Greenwood-Smith C; Lubman DI; Castle DJ
    J Psychopharmacol; 2003 Jun; 17(2):234-8. PubMed ID: 12870573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unanticipated plasma concentrations in two clozapine-treated patients.
    Alfaro CL; McClure RK; Vertrees JE; Benavides R
    Ann Pharmacother; 2001 Sep; 35(9):1028-31. PubMed ID: 11573850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoclinical strategy in neuroleptic resistant schizophrenic patients treated by clozapine: clinical evolution, concentration of plasma and red blood cell clozapine and desmethylclozapine, whole blood serotonin and tryptophan.
    Aymard N; Viala A; Baldacci C; Smagghe PO; Vacheron MN; Caroli F
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jan; 23(1):25-41. PubMed ID: 10368854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toxic plasma concentration of clozapine in inflammatory processes].
    van Gool AR; de Jong MH; Verhoeven WM
    Tijdschr Psychiatr; 2010; 52(11):791-6. PubMed ID: 21064022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical use of plasma clozapine levels.
    Bell R; McLaren A; Galanos J; Copolov D
    Aust N Z J Psychiatry; 1998 Aug; 32(4):567-74. PubMed ID: 9711372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of clozapine and relapse--a retrospective study of routine clinical data.
    Ulrich S; Baumann B; Wolf R; Lehmann D; Peters B; Bogerts B; Meyer FP
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):3-13. PubMed ID: 12564740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modafinil-associated clozapine toxicity.
    Dequardo JR
    Am J Psychiatry; 2002 Jul; 159(7):1243-4. PubMed ID: 12091210
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients.
    Dettling M; Sachse C; Brockmöller J; Schley J; Müller-Oerlinghausen B; Pickersgill I; Rolfs A; Schaub RT; Schmider J
    Psychopharmacology (Berl); 2000 Sep; 152(1):80-6. PubMed ID: 11041319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients.
    Hermida J; Paz E; Tutor JC
    Ther Drug Monit; 2008 Feb; 30(1):41-5. PubMed ID: 18223461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma clozapine and norclozapine in patients prescribed different brands of clozapine (Clozaril, Denzapine, and Zaponex).
    Couchman L; Morgan PE; Spencer EP; Johnston A; Flanagan RJ
    Ther Drug Monit; 2010 Oct; 32(5):624-7. PubMed ID: 20720516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation Between Serum Concentrations of N-Desmethylclozapine and Granulocyte Levels in Patients with Schizophrenia: A Retrospective Observational Study.
    Smith RL; Haslemo T; Andreassen OA; Eliasson E; Dahl ML; Spigset O; Molden E
    CNS Drugs; 2017 Nov; 31(11):991-997. PubMed ID: 28948574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood biogenic amines during clozapine treatment of early-onset schizophrenia.
    Schulz E; Fleischhaker C; Clement HW; Remschmidt H
    J Neural Transm (Vienna); 1997; 104(10):1077-89. PubMed ID: 9503259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.